Reading further into this new marker myoinsitol. In the studies within the link I provided. They found a rise in this chemical, affected neurodegenerate disease such as alzhiemers and huntingtons disease, in which, AUSTEDO treats Huntingtons disease. I personally find this an awesome and interesting link, and an obvious area Dr Stamler is very privy too given his alterations and apporal of AUSTEDO.
If he can get AUSTEDO to market, he sure can get ATH434 to market, so glad I found this gem of a stock.
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-164
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(16.7%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $9 | 2.573K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 22150822 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130766828 | 31 |
View Market Depth
| Last trade - 13.52pm 09/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |